medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2015, Número 5

<< Anterior Siguiente >>

Ann Hepatol 2015; 14 (5)


Gallstone disease and obesity: a population-based study on abdominal fat distribution and gender differences

Radmard AR, Merat S, Kooraki S, Ashrafi M, Keshtkar A, Sharafkhah M, Jafari E, Malekzadeh R, Poustchi H

Idioma: Ingles.
Referencias bibliográficas: 35
Paginas: 702-709
Archivo PDF: 103.57 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Russo MW, Wei JT, Thiny MT, Gangarosa LM, Brown A, Ringel Y, Shaheen NJ, et al. Digestive and liver diseases statistics. Gastroenterology 2004; 126: 1448-53.

  2. Shaffer EA. Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006; 20: 981-96.

  3. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004; 89: 2583-9.

  4. Portincasa P, Moschetta A, Palasciano G. From lipid secretion to cholesterol crystallization in bile. Relevance in cholesterol gallstone disease. Ann Hepatol 2002; 1: 121-8.

  5. Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-72.

  6. Okosun IS, Chandra KM, Choi S, Christman J, Dever GE, Prewitt TE. Hypertension and type 2 diabetes comorbidity in adults in the United States: risk of overall and regional adiposity. Obes Res 2001; 9: 1-9.

  7. Willett W. Nutritional Epidemiology. New York: Oxford University; 1990.

  8. Dubrac S, Parquet M, Blouquit Y, Gripois D, Blouquit MF, Souidi M, Lutton C. Insulin injections enhance cholesterol gallstone incidence by changing the biliary cholesterol saturation index and apo A-I concentration in hamsters fed a lithogenic diet. J Hepatol 2001; 35: 550-7.

  9. Yang YK, Chen M, Clements RH, Abrams GA, Aprahamian CJ, Harmon CM. Human mesenteric adipose tissue plays unique role versus subcutaneous and omental fat in obesity related diabetes. Cell Physiol Biochem 2008; 22:531-8.

  10. John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA. Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther 2006; 23: 1511-23.

  11. The effect of polypill on patients with presumed NASH (PolyIran- L). Available from http://clinicaltrials.gov/show/ NCT01245608 (last accessed: 5/7/2014).

  12. Chen CH, Huang MH, Yang JC, Nien CK, Etheredge GD, Yang CC, Yeh YH, et al. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey. J Gastroenterol Hepatol 2006; 21: 1737-43.

  13. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, Kato T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102: 2708-15.

  14. Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Pennell CE, de Klerk N, Oddy WH, et al. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology 2011; 53: 800-9.

  15. Kim SK, Kim HJ, Hur KY, Choi SH, Ahn CW, Lim SK, Kim KR, et al. Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases. Am J Clin Nutr 2004; 79: 593-9.

  16. Chang YR, Jang JY, Kwon W, Park JW, Kang MJ, Ryu JK, Kim YT, et al. Changes in Demographic Features of Gallstone Disease: 30 Years of Surgically Treated Patients. Gut Liver 2013; 7: 719-24.

  17. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006; 368: 230-9.

  18. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-7.

  19. Ruhl CE, Everhart JE. Relationship of serum leptin concentration and other measures of adiposity with gallbladder disease. Hepatology 2001; 34: 877-83.

  20. Hube F, Lietz U, Igel M, Jensen PB, Tornqvist H, Joost HG, Hauner H. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 1996; 28: 690-3.

  21. Hou L, Shu XO, Gao YT, Ji BT, Weiss JM, Yang G, Li HL, et al. Anthropometric Measurements, Physical Activity, and the Risk of Symptomatic Gallstone Disease in Chinese Women. Ann Epidemiol 2009;19:344-50.

  22. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr 2004; 80: 38-44.

  23. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut 2006; 55: 708-14.

  24. Brambilla P, Bedogni G, Heo M, Pietrobelli A. Waist circumference- to-height ration predicts adiposity better than body mass index in children and adolescents. Int J Obesity (Lond) 2013;37: 943-6.

  25. Hsieh SD, Yoshinaga H. Do people with similar waist circumference share similar health risks irrespective of height? Tohoku J Exp Med 1999; 188: 55-60.

  26. Armellini F, Zamboni M, Rigo L, Todesco T, Bergamo-Andreis IA, Procacci C, Bosello O. The contribution of sonography to the measurement of intra-abdominal fat. J Clin Ultrasound 1990; 18: 563-7.

  27. Tornaghi G, Raiteri R, Pozzato C, Rispoli A, Bramani M, Cipolat M, Craveri A. Anthropometric or ultrasonic measurements in assessment of visceral fat? A comparative study. Int J Obes Relat Metab Disord 1994; 18: 771-5.

  28. Stolk RP, Meijer R, Mali WP, Grobbee DE, van der Graaf Y. Secondary Manifestations of Arterial Disease Study Group. Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. Am J Clin Nutr 2003; 77: 857-60.

  29. Liu KH, Chan YL, Chan WB, Kong WL, Kong MO, Chan JC. Sonographic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes. Int J Obes Relat Metab Disord 2003; 27: 1267-73.

  30. Meriño-Ibarra E, Artieda M, Cenarro A, Goicoechea J, Calvo L, Guallar A, Civeira F. Ultrasonography for the evaluation of visceral fat and the metabolic syndrome. Metabolism 2005; 54: 1230-5.

  31. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord 2004; 28: 1018-25.

  32. Ibrahim MM. Subcutaneous and visceral adipose tissue: Structural and functional differences. Obes Rev 2010; 11: 11-8.

  33. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B. Regulation of adiponectin by adipose tissuederived cytokines: in vivo an in vitro investigations in human. Am J Physiol Endocrinol Metab 2003; 285: E527- E533.

  34. Nepokroeff CM, Lakshmanan MR, Ness GC, Dugan RE, Porter JW. Regulation of the diurnal rhythm of rat liver betahydroxy- betamethylglutaryl coenzyme A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone. Arch Biochem Biophys 1974; 160: 387-96.

  35. Gielkens HA, Lam WF, Coenraad M, Frölich M, van Oostayen JA, Lamers CB, Masclee AA. Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans. J Hepatol 1998; 28: 595-602.




2020     |     www.medigraphic.com